Target intelligence / Profile preview

Damaged Myocardium (None)

Target
None
Molecular classification
Tissue, Heart Muscle
01

Overview

Damaged myocardium refers to injury or death of the heart muscle (myocardium), most commonly resulting from insufficient blood supply (ischemia) due to blockage or narrowing of the coronary arteries. This damage can be acute, as in myocardial infarction (heart attack), or chronic, as seen in conditions like hibernating myocardium. Damaged myocardium is not a direct drug target; instead, therapeutic interventions aim to limit further damage, restore blood flow, and manage the consequences of the damage.

02

Mechanism of action

Varied, depending on the cause and drug. Examples include: reducing thrombus formation, lowering cholesterol, reducing blood pressure, blocking adrenergic receptors.

03

Biological functions

Cardiac contractionBlood pumpingCardiac output
04

Disease associations

Myocardial infarctionHeart failureIschemic heart diseaseMyocarditis
05

Safety considerations

ArrhythmiasHeart failureCardiogenic shockBleeding (with thrombolytics/antiplatelets)
06

Interacting drugs

Antiplatelets

4 more in the full profile.

07

Biomarkers

Cardiac troponinCreatine kinase-MBECG changes (ST-segment elevation/depression)Wall motion abnormalities on echocardiography/MRI

Beyond the preview

Go deeper on Damaged Myocardium (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Damaged Myocardium (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call